We've been carrying supplements to Diagnostic Imaging for a long time. We view them as a way to bring you added information on selected topics that we cover in less detail within the magazine. This month we have three.
We've been carrying supplements to Diagnostic Imaging for a long time. We view them as a way to bring you added information on selected topics that we cover in less detail within the magazine. This month we have three.
A PACS and Informatics supplement appears in this issue as a "magazine within a magazine." The material in the supplement reflects our continued focus on informatics developments as they pertain to radiologists. A version of this supplement will be sent to hospital and enterprise executives who deal with the informatics systems that connect and merge those enterprises and who need to understand the imaging element of informatics.
The Imaging & Oncology supplement reflects a collaborative effort with one of our sister publications, Oncology News International, which will also distribute this material. We hope to achieve two goals here: informing oncologists about the how and why of oncology imaging, and giving radiologists a stronger sense of how oncology uses imaging information.
The Cardiovascular CT supplement looks at an area we know is drawing increasing attention in the medical imaging community. We've covered cardiovascular imaging and MR cardiovascular imaging in the past. But this supplement, along with a more clinical one that appeared in December, brings the focus to the emerging role of CT, particularly the innovations of radiologists working to bring this technology to daily practice.
Together, the three reflect an important trend in radiology: The reach of medical imaging is expanding, and we need to communicate its use and value to others who work with radiology. Providing information that achieves that goal is part of our mission.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.